Literature DB >> 16627618

The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway.

Ji-Young Min1, Robert M Krug.   

Abstract

The NS1 protein of influenza A virus (NS1A protein) is a multifunctional protein that counters cellular antiviral activities and is a virulence factor. Its N-terminal RNA-binding domain binds dsRNA. The only amino acid absolutely required for dsRNA binding is the R at position 38. To identify the role of this dsRNA-binding activity during influenza A virus infection, we generated a recombinant influenza A/Udorn/72 virus expressing an NS1A protein containing an RNA-binding domain in which R38 is mutated to A. This R38A mutant virus is highly attenuated, and the mutant NS1A protein, like the WT protein, is localized in the nucleus. Using the R38A mutant virus, we establish that dsRNA binding by the NS1A protein does not inhibit production of IFN-beta mRNA. Rather, we demonstrate that the primary role of this dsRNA-binding activity is to protect the virus against the antiviral state induced by IFN-beta. Pretreatment of A549 cells with IFN-beta for 6 h did not inhibit replication of WT Udorn virus, whereas replication of R38A mutant virus was inhibited 1,000-fold. Using both RNA interference in A549 cells and mouse knockout cells, we show that this enhanced sensitivity to IFN-beta-induced antiviral activity is due predominantly to the activation of RNase L. Because activation of RNase L is totally dependent on dsRNA activation of 2'-5' oligo (A) synthetase (OAS), it is likely that the primary role of dsRNA binding by the NS1A protein in virus-infected cells is to sequester dsRNA away from 2'-5' OAS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627618      PMCID: PMC1459024          DOI: 10.1073/pnas.0602184103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  In or out? Regulating nuclear transport.

Authors:  J K Hood; P A Silver
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

Review 2.  Novel functions of interferon-induced proteins.

Authors:  G C Sen
Journal:  Semin Cancer Biol       Date:  2000-04       Impact factor: 15.707

3.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Influenza virus virulence and its molecular determinants.

Authors:  Diana L Noah; Robert M Krug
Journal:  Adv Virus Res       Date:  2005       Impact factor: 9.937

6.  Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA.

Authors:  J M Ryter; S C Schultz
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

7.  The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.

Authors:  Karen Y Twu; Diana L Noah; Ping Rao; Rei-Lin Kuo; Robert M Krug
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  RNA recognition by a Staufen double-stranded RNA-binding domain.

Authors:  A Ramos; S Grünert; J Adams; D R Micklem; M R Proctor; S Freund; M Bycroft; D St Johnston; G Varani
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

9.  RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids.

Authors:  W Wang; K Riedel; P Lynch; C Y Chien; G T Montelione; R M Krug
Journal:  RNA       Date:  1999-02       Impact factor: 4.942

Review 10.  Influenza: lessons from past pandemics, warnings from current incidents.

Authors:  Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Nat Rev Microbiol       Date:  2005-08       Impact factor: 60.633

View more
  236 in total

1.  Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response.

Authors:  Sabine Steidle; Luis Martínez-Sobrido; Markus Mordstein; Stefan Lienenklaus; Adolfo García-Sastre; Peter Stäheli; Georg Kochs
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Phylogenetic analysis of the non-structural (NS) gene of influenza A viruses isolated in Kazakhstan in 2002-2009.

Authors:  Andrey Bogoyavlenskiy; Vladimir Berezin; Alexey Prilipov; Ilya Korotetskiy; Irina Zaitseva; Aydyn Kydyrmanov; Kobey Karamedin; Nailya Ishmukhametova; Saule Asanova; Marat Sayatov; Kainar Zhumatov
Journal:  Virol Sin       Date:  2011-12-10       Impact factor: 4.327

3.  Intracellular distribution of NS1 correlates with the infectivity and interferon antagonism of an avian influenza virus (H7N1).

Authors:  Bjoern Keiner; Benjamin Maenz; Ralf Wagner; Giovanni Cattoli; Ilaria Capua; Hans-Dieter Klenk
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

4.  NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response.

Authors:  Zhongfang Wang; Nicole C Robb; Eva Lenz; Thorsten Wolff; Ervin Fodor; Stephan Pleschka
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

5.  Exploring naphthyl-carbohydrazides as inhibitors of influenza A viruses.

Authors:  Sanmitra Barman; Lei You; Ran Chen; Vlad Codrea; Grace Kago; Ramakrishna Edupuganti; Jon Robertus; Robert M Krug; Eric V Anslyn
Journal:  Eur J Med Chem       Date:  2013-11-07       Impact factor: 6.514

6.  Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus.

Authors:  C R Baskin; H Bielefeldt-Ohmann; A García-Sastre; T M Tumpey; N Van Hoeven; V S Carter; M J Thomas; S Proll; A Solórzano; R Billharz; J L Fornek; S Thomas; C-H Chen; E A Clark; Kaja Murali-Krishna; M G Katze
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

7.  Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds.

Authors:  Alex B Kleinpeter; Alexander S Jureka; Sally M Falahat; Todd J Green; Chad M Petit
Journal:  J Biol Chem       Date:  2018-08-03       Impact factor: 5.157

8.  Interferon Inducer IFI35 regulates RIG-I-mediated innate antiviral response through mutual antagonism with Influenza protein NS1.

Authors:  Hui Yang; Wendy Winkler; Xiaopeng Wu
Journal:  J Virol       Date:  2021-03-10       Impact factor: 5.103

9.  Influenza A Virus Protein NS1 Exhibits Strain-Independent Conformational Plasticity.

Authors:  Sayantan Mitra; Dilip Kumar; Liya Hu; Banumathi Sankaran; Mahdi Muhammad Moosa; Andrew P Rice; Josephine C Ferreon; Allan Chris M Ferreon; B V Venkataram Prasad
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

10.  Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells.

Authors:  Irene Ramos; Elena Carnero; Dabeiba Bernal-Rubio; Christopher W Seibert; Liset Westera; Adolfo García-Sastre; Ana Fernandez-Sesma
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.